Biomarker & Bioanalytical Strategy Lead, RNA Therapeutics
Borealis Biosciences, Inc. is seeking a Biomarker & Bioanalytical Development Lead to own the bioanalytical and biomarker strategy across the RNA therapeutics portfolio.
This senior scientist will design, build, and oversee assays measuring drug exposure, target engagement, pharmacodynamic response, and safety to support IND-enabling nonclinical and early clinical development. The role focuses on preparing for a Phase 1/2 trial, including development and transfer of regulated PK assays,
Are you ready to take on the Biomarker & Bioanalytical Strategy Lead, RNA Therapeutics role at Borealis Biosciences, Inc.?
The advertised compensation is 288..
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.
Learn more about the Biomarker & Bioanalytical Strategy Lead, RNA Therapeutics role in the description above.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).